Last update 21 Nov 2024

CD-2475-101

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Mechanism-
Therapeutic Areas
Skin and Musculoskeletal Diseases
Active Indication
Acne Vulgaris
Inactive Indication
Visible Lesion
Originator Organization
Galderma Holding SAGalderma Holding SA
Active Organization
Galderma International SAS
Inactive Organization
Galderma Holding SAGalderma Holding SAGalderma Research & Development SNC
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CD-2475-101
NCT01320033 / CompletedPhase 2
A Multi Center, Randomized, Double Blind, Placebo Controlled, 3 Arm, Parallel Group Study Comparing the Efficacy and Safety of CD2475/101 40 mg Tablets Versus Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions in Subjects With Acne Vulgaris
100 Clinical Results associated with CD-2475-101
Login to view more data
100 Translational Medicine associated with CD-2475-101
Login to view more data
100 Patents (Medical) associated with CD-2475-101
Login to view more data
100 Deals associated with CD-2475-101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acne VulgarisPhase 2-
Galderma International SAS
-
Visible LesionPreclinical
US
Galderma Holding SAGalderma Holding SA
29 Mar 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT01320033 (CTgov)
Phase 2
Visible Lesion | Acne Vulgaris
662
(CD2475/101 40 mg)
iwkxgocqca(xxmhmmbvdq) = itrpplksuy epxrchknpl (jvepgxmwcv, cmjapnguak - drdpxshpch)
View more
-
10 Feb 2020
(Doxycycline 100 mg)
iwkxgocqca(xxmhmmbvdq) = mwjsznzkna epxrchknpl (jvepgxmwcv, kuminsmyai - fpieuwkzpo)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free